Filings under SCNI by Scanner Technologies Corp (CIK 0000217222) from Jun 8, 2006 to Jan 11, 2008 belong to a different issuer and are not shown.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 16, 2026 | Reichman Amir | Chief Executive Officer, Director | Grant(A) | 400.0M | — | $0 |
| Jun 16, 2026 | Germain Mark | Director | Grant(A) | 120.0M | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Scinai Immunotherapeutics Ltd., SEC CIK 0001611747. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under SCNI and shows every filing by that issuer. Earlier filings under the same symbol by another issuer are left out.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-05. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for SCNI